Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FRET Assay for REV-ERB Ligands from US Patent US20240002380: "REV-ERB AGONISTS"
Assay data:20 Active, 20 Activity ≤ 1 µM, 26 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Dual reporter qHTS for antagonist of Pregnane X Receptor (hPXR) against the NCATS DSHEA and TCM libraries: Fluorescence Readout
Assay data:28 Active, 4 Activity ≤ 1 µM, 964 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Dual reporter qHTS for antagonist of Pregnane X Receptor (hPXR) against the NCATS DSHEA and TCM libraries: Luminescence Readout
Assay data:11 Active, 8 Activity ≤ 1 µM, 964 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Dual reporter qHTS for agonist of Pregnane X Receptor (hPXR) against the NCATS DSHEA and TCM libraries: Luminescence readout
Assay data:82 Active, 964 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Dual reporter qHTS for agonist of Pregnane X Receptor (hPXR) against the NCATS DSHEA and TCM libraries: Fluorescence readout
Assay data:1 Active, 3 Activity ≤ 1 µM, 964 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
GR Binding Assay from US Patent US11834458: "Anti-cancer nuclear hormone receptor-targeting compounds"
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
AR Binding Assay from US Patent US11834458: "Anti-cancer nuclear hormone receptor-targeting compounds"
Assay data:11 Active, 13 Activity ≤ 1 µM, 13 Tested
ER Binding Assay from US Patent US11834458: "Anti-cancer nuclear hormone receptor-targeting compounds"
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
BIOLOGICAL ACTIVITY from US Patent US20230382870: "N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF"
Assay data:31 Active, 31 Activity ≤ 1 µM, 31 Tested
ER Binding Assay from US Patent US11826430: "Anti-cancer nuclear hormone receptor-targeting compounds"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
AR Binding Assay from US Patent US11826430: "Anti-cancer nuclear hormone receptor-targeting compounds"
Assay data:5 Active, 2 Activity ≤ 1 µM, 6 Tested
In Vitro Assay-LXRβ from US Patent US20230340011: "STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS"
Assay data:151 Active, 93 Activity ≤ 1 µM, 472 Tested
Androgen Receptor (AR) Radioligand Binding Assay from US Patent US11787812: "Substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1 -f][1,2,4]triazines as androgen receptor and phosphodiesterase dual inhibitors"
Assay data:13 Active, 20 Activity ≤ 1 µM, 20 Tested
GR Binding Assay from US Patent US11787780: "Quaternary indazole glucocorticoid receptor antagonists"
Assay data:255 Active, 232 Activity ≤ 1 µM, 255 Tested
Cell free binding to the Glucocorticoid Receptor (GR) in LanthaScreen TR-FRET GR Competitive Binding Assay from US Patent US11760775: "Steroids and protein-conjugates thereof"
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Gal4 Ligand Binding Assay from US Patent US20230277527: "ROR-GAMMA MODULATORS"
Assay data:17 Active, 12 Activity ≤ 1 µM, 20 Tested
FXR Ligand Binding Assay from US Patent US11718619: "Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators"
Assay data:57 Active, 57 Activity ≤ 1 µM, 63 Tested
In Vitro Testing of Androgen Receptor Assay from US Patent US11691960: "2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament"
Assay data:4 Active, 4 Activity ≤ 1 µM, 7 Tested
LanthaScreen Competitive Binding Assay from US Patent US11672785: "Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs"
Assay data:7 Active, 2 Activity ≤ 1 nM, 7 Activity ≤ 1 µM, 7 Tested
Human Androgen Receptor (hAR) Ligand Binding Domain (LBD) Affinity Assay from US Patent US11648234: "Selective androgen receptor degrader (SARD) ligands and methods of use"
Assay data:50 Active, 32 Activity ≤ 1 µM, 50 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on